Anna Simon Selected Research

Breast Neoplasms (Breast Cancer)

3/2020

Metastatic breast cancer cells induce altered microglial morphology and electrical excitability in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anna Simon Research Topics

Disease

16	Mevalonate Kinase Deficiency 01/2022 - 05/2004
16	Fever (Fevers) 09/2021 - 05/2004
12	Inflammation (Inflammations) 01/2017 - 05/2004
8	Familial Mediterranean Fever (Periodic Disease) 09/2021 - 01/2007
6	Cryopyrin-Associated Periodic Syndromes 01/2022 - 01/2007
5	Infections 01/2021 - 04/2008
5	Gastroenteritis 01/2019 - 08/2009
5	autosomal dominant familial Periodic fever 05/2013 - 01/2007
4	Necrosis 01/2022 - 05/2013
4	Schnitzler Syndrome 12/2011 - 12/2007
2	Thyrotoxicosis 01/2022 - 01/2020
2	Reinfection 01/2021 - 08/2014
2	Exanthema (Rash) 07/2015 - 06/2015
2	Arthritis (Polyarthritis) 06/2015 - 05/2013
2	Renal Insufficiency (Renal Failure) 12/2013 - 01/2013
2	Pyogenic arthritis, pyoderma gangrenosum, and acne 05/2013 - 01/2007
2	Porcine Reproductive and Respiratory Syndrome (PRRS) 09/2012 - 01/2012
1	Congenital adrenal hyperplasia due to 11-Beta-hydroxylase deficiency 12/2021
1	Brain Diseases (Brain Disorder) 09/2021
1	Thrombocytopenia (Thrombopenia) 09/2021
1	Neurologic Manifestations (Neurological Manifestations) 09/2021
1	Aicardi-Goutieres syndrome 09/2021
1	Congenital Hypothyroidism (Cretinism) 07/2021
1	Primary Immunodeficiency Diseases 01/2021
1	Diabetes Insipidus 01/2021
1	Gaucher Disease (Gaucher's Disease) 01/2021
1	Obesity 01/2021
1	Breast Neoplasms (Breast Cancer) 03/2020
1	Hypothyroidism 01/2020
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 12/2019
1	Hypogonadism (Hypergonadotropic Hypogonadism) 05/2019
1	Familial Hypoadrenocorticism 05/2019
1	Schizophrenia (Dementia Praecox) 01/2019
1	Nervous System Diseases (Neurological Disorders) 01/2019
1	Congenital Hyperinsulinism 01/2018
1	Birth Weight (Birth Weights) 12/2017
1	Hereditary renal agenesis 12/2017
1	Solitary Kidney 12/2017
1	Arthralgia (Joint Pain) 07/2015
1	Adult-Onset Still's Disease 06/2015
1	Injection Site Reaction 06/2015
1	Osteomyelitis 03/2015
1	Autosomal Recessive 31 Deafness 02/2015
1	Multiple Sclerosis 11/2014
1	Febrile Seizures (Febrile Seizure) 09/2014

Drug/Important Bio-Agent (IBA)

6	canakinumab FDA Link 01/2022 - 12/2011
6	Interleukin-1 (Interleukin 1)IBA 01/2022 - 01/2008
6	Immunoglobulin D (IgD)IBA 09/2011 - 05/2004
5	CytokinesIBA 03/2015 - 01/2009
4	Colchicine FDA LinkGeneric 09/2021 - 01/2013
4	mevalonate kinaseIBA 01/2019 - 11/2008
4	Proteins (Proteins, Gene)FDA Link 07/2015 - 02/2009
4	InflammasomesIBA 12/2012 - 01/2007
3	VaccinesIBA 01/2019 - 04/2012
3	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2019 - 05/2010
3	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 12/2017 - 02/2015
3	Biomarkers (Surrogate Marker)IBA 01/2017 - 11/2014
3	Interleukin-1beta (Interleukin 1 beta)IBA 07/2015 - 01/2007
2	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2022 - 01/2022
2	Thyroid HormonesIBA 01/2022 - 01/2020
2	EnzymesIBA 09/2021 - 04/2012
2	AcidsIBA 01/2021 - 03/2013
2	Mevalonic Acid (Mevalonate)IBA 01/2021 - 12/2013
2	CholesterolIBA 01/2021 - 11/2014
2	Toll-Like Receptors (Toll-Like Receptor)IBA 07/2015 - 11/2014
2	AA amyloidosisIBA 01/2013 - 12/2007
2	Pattern Recognition ReceptorsIBA 09/2012 - 01/2012
2	Type I Tumor Necrosis Factor ReceptorsIBA 03/2011 - 05/2010
1	Steroid 11-beta-Hydroxylase (11 beta-Hydroxylase)IBA 12/2021
1	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 07/2021
1	SPADIBA 01/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2021
1	GlucosidasesIBA 01/2021
1	Glucosylceramidase (Glucocerebrosidase)IBA 01/2021
1	Glucosylceramides (Glucocerebrosides)IBA 01/2021
1	Hormones (Hormone)IBA 01/2021
1	Immunoglobulin G (IgG)IBA 01/2021
1	Polysaccharides (Glycans)IBA 01/2021
1	Immunoglobulins (Immunoglobulin)IBA 01/2021
1	fluorescent protein 583IBA 03/2020
1	matrigelIBA 03/2020
1	DAX-1 Orphan Nuclear ReceptorIBA 05/2019
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2019
1	Diazoxide (Hyperstat)FDA Link 01/2018
1	Sirolimus (Rapamycin)FDA Link 01/2018
1	N 30IBA 07/2016
1	LigandsIBA 07/2015
1	Prednisone (Sone)FDA LinkGeneric 06/2015
1	Ferritins (Ferritin)IBA 06/2015
1	tocilizumab (atlizumab)FDA Link 02/2015
1	Terpenes (Terpenoids)IBA 02/2015
1	Cytokine Receptors (Cytokine Receptor)IBA 11/2014
1	Interferon Type IIBA 11/2014

Therapy/Procedure

2	Therapeutics 01/2021 - 01/2018
2	Immunomodulation 08/2014 - 01/2012
1	Aftercare (After-Treatment) 01/2021
1	Antibiotic Prophylaxis 01/2021
1	Glycemic Control 12/2019
1	Organ Transplantation 01/2017
1	Subcutaneous Injections 06/2015